Performance of p16(INK4a) ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study

OBJECTIVE: A biomarker with increased specificity for cervical dysplasia compared with human papillomavirus (HPV) testing would be an attractive option for cervical cancer screening among HIV-infected women in resource-limited settings. p16(INK4a) has been explored as a biomarker for screening in ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tara J, Smith-McCune, Karen, Reuschenbach, Miriam, von Knebel Doeberitz, Magnus, Maloba, May, Huchko, Megan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030582/
https://www.ncbi.nlm.nih.gov/pubmed/27625065
http://dx.doi.org/10.1136/bmjopen-2016-012547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030582/
https://www.ncbi.nlm.nih.gov/pubmed/27625065
http://dx.doi.org/10.1136/bmjopen-2016-012547

Ejemplares similares